Diagnosis and management of nonmelanoma skin cancer
This article describes the main types of NMSC and their clinical presentations, and discusses the management options available. (Source: Prescriber)
Source: Prescriber - May 31, 2017 Category: Primary Care Authors: Janet Angus Tags: Therapy Review Source Type: research
The Gateway ‐C project: helping GPs to detect cancer earlier
This article focuses on that project and its aims. (Source: Prescriber)
Source: Prescriber - May 31, 2017 Category: Primary Care Authors: Angela Dowden Tags: Education Source Type: research
Rising to the challenge of male hormonal contraception
Despite decades of research, and surveys showing that the majority of men are willing to try it, a reversible male hormonal contraceptive (MHC) has not yet reached the market. There have been many scientific and regulatory barriers to development but recent advances indicate that MHC is at last a realistic prospect. (Source: Prescriber)
Source: Prescriber - May 31, 2017 Category: Primary Care Authors: Mark Greener Tags: Research Source Type: research
Preparing medical students for the realities of NHS prescribing
Professor Simon Maxwell is medical director of the Prescribing Safety Assessment (PSA) and professor of student learning at the University of Edinburgh Medical School. He is also a consultant physician at the Western General Hospital in Edinburgh. He talks to Kate Stewart about the PSA and the impact it is having on prescribing education in the UK and beyond. (Source: Prescriber)
Source: Prescriber - May 31, 2017 Category: Primary Care Authors: Kate Stewart Tags: Profile Source Type: research
Treating scabies infestations in children and adults
This article describes how to recognise a scabies infestation and examines the efficacy and suitability of the various treatment options. (Source: Prescriber)
Source: Prescriber - May 31, 2017 Category: Primary Care Authors: Chin Whybrew Tags: Drug Review Source Type: research
Seeking more investment to create a world ‐class NHS
The Association of the British Pharmaceutical Industry (ABPI) held its annual conference in April to launch its own General Election manifesto and present a wide variety of speakers from the NHS, industry, patient groups, academia and UK political parties. Joy Ogden reports on the organisation's future industrial strategy. (Source: Prescriber)
Source: Prescriber - May 31, 2017 Category: Primary Care Authors: Joy Ogden Tags: News Feature Source Type: research
PPIs and hypomagnesaemia: more common than we thought?
Proton pump inhibitors (PPIs) are associated with several well‐documented side‐effects but one emerging adverse effect, hypomagnesaemia, has so far tended to slip under the radar. In a small audit, the author investigated the rates of magnesium supplementation among PPI users, as a potential indicator of hypomagnesaemia. The results suggest this side‐effect could be more common than previously thought. (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Angus Thompson Tags: Postscript Source Type: research
Qtern: DPP ‐4 and SGLT2 inhibitor combination for type 2 diabetes
This article discusses its indications, place in therapy and clinical trial efficacy. (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Steve Chaplin Tags: New Products Source Type: research
Can drug price hikes via debranding be prevented?
Steep price hikes following the debranding of off‐patent medicines are becoming increasingly common in the UK, adding hundreds of millions to the NHS drugs bill. But can anything be done to prevent this? (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Farasat Bokhari, Bruce Lyons Tags: Drug Pricing Source Type: research
QALYs and their role in the NICE decision ‐making process
In the third article in our series on NICE guidance, we discuss Quality‐Adjusted Life Years (QALYs), a key calculation used by NICE when assessing the cost‐effectiveness of new treatments. (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Joy Ogden Tags: Guidelines Source Type: research
ADA position statement on diabetic neuropathy
The American Diabetes Association (ADA)'s recent position statement provides a useful summary of the current evidence on the prevention and management of diabetic neuropathy. (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Steve Chaplin Tags: Position Statement Source Type: research
Biosimilars: ensuring safety in the search for savings
Biosimilars – cheaper versions of biopharmaceuticals produced by competing companies – have the potential to reduce the NHS drugs bill substantially. However, unlike generic drugs, biosimilars are not interchangeable with the original brand, raising safety concerns. Hence pharmacovigilance and prescribing by brand is essential. (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Mark Greener Tags: Drug Development Source Type: research
Summary of the National Diabetes Audit 2015 –16 report
The most recent National Diabetes Audit report on care processes and treatment targets1 shows that some progress is being made in NHS diabetes care, but there is still a large variation across England and Wales. (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Steve Chaplin Tags: Report Source Type: research
New roles for clinical pharmacists in general practice
In 2015, NHS England launched its scheme to fund, recruit and employ more clinical pharmacists in GP practices. Since then, pharmacists have been playing an increasingly essential role in general practice, not only by reducing the workload of GPs but by bringing additional skills and knowledge on medicines optimisation, particularly in cases of complex polypharmacy. (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Eleanor Barnes, Imran Ashraf, Aysha Din Tags: Medicines Optimisation Source Type: research
Individualising treatment and care of patients with diabetes
Individualising the treatment and care of patients with diabetes was a key theme at the 2016 Diabetes Professional Care conference held in London last November. Susan Mayor reports on how to assess individual patients' characteristics to set appropriate targets and how to make treatment decisions based on these targets. (Source: Prescriber)
Source: Prescriber - May 2, 2017 Category: Primary Care Authors: Susan Mayor Tags: Conference Report Source Type: research
